Your browser doesn't support javascript.
loading
Dupilumab as Effective Therapy for Corticosteroid Dependent/Resistant Type 2 Inflammation-Related Cutaneous Adverse Reactions
Shen, C; Wu, N; Yang, L; Wang, B; Liu, T; Tao, J.
Affiliation
  • Shen, C; Huazhong University of Science and Technology. Tongji Medical College. Union Hospital. Wuhan. China
  • Wu, N; Huazhong University of Science and Technology. Tongji Medical College. Union Hospital. Wuhan. China
  • Yang, L; Huazhong University of Science and Technology. Tongji Medical College. Union Hospital. Wuhan. China
  • Wang, B; University of Michigan. Department of Dermatology. Ann Arbor. United States
  • Liu, T; Huazhong University of Science and Technology. Tongji Medical College. Union Hospital. Wuhan. China
  • Tao, J; Huazhong University of Science and Technology. Tongji Medical College. Union Hospital. Wuhan. China
J. investig. allergol. clin. immunol ; 34(2): 145-147, 2024. graf
Article in English | IBECS | ID: ibc-ADZ-347
Responsible library: ES1.1
Localization: ES15.1 - BNCS
Subject(s)

Fulltext
Add to My VHL
Print
XML
Search on Google

Full text: Available Collection: National databases / Spain Health context: SDG3 - Target 3.8 Achieve universal access to health / Sustainable Health Agenda for the Americas / SDG3 - Health and Well-Being / SDG3 - Target 3.4 Reduce premature mortality due to noncommunicable diseases / SDG3 - Target 3.2 Reduce avoidable death in newborns and children under 5 Health problem: Delivery Arrangements / Goal 10: Communicable diseases / Target 3.3: End transmission of communicable diseases / Target 3.1: Reduce maternal mortality / Target 3.2: Reduce avoidable death in newborns and children under 5 / Sickle Cell Disorders / Neonatal Healthcare / Noncommunicable Diseases Database: IBECS Main subject: Antitussive Agents / Referral and Consultation / Scopolamine / Skin Diseases / Specimen Handling / Therapeutics / Vitamin D / Biological Products / Drug Resistance / Esophageal Neoplasms Type of study: Controlled clinical trial / Diagnostic study / Incidence study / Observational study / Prognostic study / Risk factors / Screening study Aspects: Patient-preference Limits: Humans / Female / Male / Child / Aged / Infant, Newborn Country/Region as subject: Europa Language: English / Spanish Journal: J. investig. allergol. clin. immunol / Actas dermo-sifiliogr. (Ed. impr.) / Allergol. immunopatol / Arch. Soc. Esp. Oftalmol / Bol. pediatr / Clin. transl. oncol. (Print) / Iberoam. j. med / Nutr. hosp / Rev. esp. enferm. dig / Rev. int. med. cienc. act. fis. deporte Year: 2021 / 2023 / 2022 / 2024 Document type: Article Institution/Affiliation country: Ayuntamiento de Madrid/España / Casa di Cura Villa Montallegro/Italy / Centro de Hemoterapia y Hemodonación de Castilla y León/España / Complejo Asistencial Universitario de León/España / Dr. DY Patil University/India / Faculty of Medicine of Tunisia/Túnez / Fundación Piel Sana AEDV/España / Gaochun People’s Hospital/China / Hospital Clínico Universitario de Valladolid/España / Hospital General de Baza/España
Fulltext
Add to My VHL
Print
XML
Search on Google

Full text: Available Collection: National databases / Spain Health context: SDG3 - Target 3.8 Achieve universal access to health / Sustainable Health Agenda for the Americas / SDG3 - Health and Well-Being / SDG3 - Target 3.4 Reduce premature mortality due to noncommunicable diseases / SDG3 - Target 3.2 Reduce avoidable death in newborns and children under 5 Health problem: Delivery Arrangements / Goal 10: Communicable diseases / Target 3.3: End transmission of communicable diseases / Target 3.1: Reduce maternal mortality / Target 3.2: Reduce avoidable death in newborns and children under 5 / Sickle Cell Disorders / Neonatal Healthcare / Noncommunicable Diseases Database: IBECS Main subject: Antitussive Agents / Referral and Consultation / Scopolamine / Skin Diseases / Specimen Handling / Therapeutics / Vitamin D / Biological Products / Drug Resistance / Esophageal Neoplasms Type of study: Controlled clinical trial / Diagnostic study / Incidence study / Observational study / Prognostic study / Risk factors / Screening study Aspects: Patient-preference Limits: Humans / Female / Male / Child / Aged / Infant, Newborn Country/Region as subject: Europa Language: English / Spanish Journal: J. investig. allergol. clin. immunol / Actas dermo-sifiliogr. (Ed. impr.) / Allergol. immunopatol / Arch. Soc. Esp. Oftalmol / Bol. pediatr / Clin. transl. oncol. (Print) / Iberoam. j. med / Nutr. hosp / Rev. esp. enferm. dig / Rev. int. med. cienc. act. fis. deporte Year: 2021 / 2023 / 2022 / 2024 Document type: Article Institution/Affiliation country: Ayuntamiento de Madrid/España / Casa di Cura Villa Montallegro/Italy / Centro de Hemoterapia y Hemodonación de Castilla y León/España / Complejo Asistencial Universitario de León/España / Dr. DY Patil University/India / Faculty of Medicine of Tunisia/Túnez / Fundación Piel Sana AEDV/España / Gaochun People’s Hospital/China / Hospital Clínico Universitario de Valladolid/España / Hospital General de Baza/España